Published in Neurology on April 08, 2003
Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med (2011) 4.02
Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J Neurosci (2009) 2.24
Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog Neurobiol (2010) 1.54
Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol (2007) 1.51
Spinal cord gray matter atrophy correlates with multiple sclerosis disability. Ann Neurol (2014) 1.50
Cortical lesions in multiple sclerosis. Nat Rev Neurol (2010) 1.47
Cognition in the early stage of multiple sclerosis. J Neurol (2006) 1.37
Multiple sclerosis normal-appearing white matter: pathology-imaging correlations. Ann Neurol (2011) 1.35
Association of retinal and macular damage with brain atrophy in multiple sclerosis. PLoS One (2011) 1.35
Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla. Brain (2010) 1.27
Meningeal and cortical grey matter pathology in multiple sclerosis. BMC Neurol (2012) 1.27
Revisiting brain atrophy and its relationship to disability in multiple sclerosis. PLoS One (2012) 1.26
Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis. NeuroRx (2004) 1.23
Segmentation of brain magnetic resonance images for measurement of gray matter atrophy in multiple sclerosis patients. Neuroimage (2008) 1.21
Aerobic fitness is associated with gray matter volume and white matter integrity in multiple sclerosis. Brain Res (2009) 1.18
Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes. PLoS One (2012) 1.16
Quantification and clinical relevance of brain atrophy in multiple sclerosis: a review. J Neurol (2009) 1.08
Localization of grey matter atrophy in early RRMS : A longitudinal study. J Neurol (2006) 1.06
Does high-field MR imaging improve cortical lesion detection in multiple sclerosis? J Neurol (2008) 1.05
Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis. PLoS One (2011) 1.05
Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients. PLoS One (2013) 1.04
Gray matter imaging in multiple sclerosis: what have we learned? BMC Neurol (2011) 1.03
In vivo evidence of disseminated subpial T2* signal changes in multiple sclerosis at 7 T: a surface-based analysis. Neuroimage (2011) 1.03
Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis. Neurology (2015) 1.01
Normal-appearing white and grey matter damage in MS. A volumetric and diffusion tensor MRI study at 3.0 Tesla. J Neurol (2007) 1.01
Brain atrophy correlates with functional outcome in a murine model of multiple sclerosis. Neuroimage (2010) 0.97
Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry (2004) 0.95
Clinical correlates of grey matter pathology in multiple sclerosis. BMC Neurol (2012) 0.94
Axon loss is an important determinant of weakness in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry (2006) 0.93
Cognition in multiple sclerosis: relevance of lesions, brain atrophy and proton MR spectroscopy. Neurol Sci (2010) 0.93
Heterogeneity in multiple sclerosis: scratching the surface of a complex disease. Autoimmune Dis (2010) 0.92
Evidence of diffuse damage in frontal and occipital cortex in the brain of patients with post-traumatic stress disorder. Neurol Sci (2011) 0.91
Regional cortical thickness in relapsing remitting multiple sclerosis: A multi-center study. Neuroimage Clin (2012) 0.91
Therapeutic laquinimod treatment decreases inflammation, initiates axon remyelination, and improves motor deficit in a mouse model of multiple sclerosis. Brain Behav (2013) 0.90
Multiple sclerosis: autoimmunity and viruses. Curr Opin Rheumatol (2013) 0.89
Sensitivity and reproducibility of a new fast 3D segmentation technique for clinical MR-based brain volumetry in multiple sclerosis. Neuroradiology (2004) 0.89
Diffuse cortical atrophy in a marmoset model of multiple sclerosis. Neurosci Lett (2008) 0.89
Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models. Acta Neuropathol (2013) 0.89
Relationships between gray matter metabolic abnormalities and white matter inflammation in patients at the very early stage of MS : a MRSI study. J Neurol (2007) 0.89
A voxel-based morphometry study of disease severity correlates in relapsing-- remitting multiple sclerosis. Mult Scler (2009) 0.89
Cortical atrophy in experimental autoimmune encephalomyelitis: in vivo imaging. Neuroimage (2011) 0.88
Progression of non-age-related callosal brain atrophy in multiple sclerosis: a 9-year longitudinal MRI study representing four decades of disease development. J Neurol Neurosurg Psychiatry (2006) 0.87
Axonal damage in multiple sclerosis. Mt Sinai J Med (2011) 0.87
A hybrid geometric-statistical deformable model for automated 3-D segmentation in brain MRI. IEEE Trans Biomed Eng (2009) 0.86
Non-Gaussian diffusion MRI of gray matter is associated with cognitive impairment in multiple sclerosis. Mult Scler (2014) 0.86
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis. Nat Rev Neurol (2015) 0.85
Corpus callosum index and long-term disability in multiple sclerosis patients. J Neurol (2010) 0.85
Structural and metabolic damage in brains of patients with SPG11-related spastic paraplegia as detected by quantitative MRI. J Neurol (2011) 0.84
A longitudinal observational study of brain atrophy rate reflecting four decades of multiple sclerosis: a comparison of serial 1D, 2D, and volumetric measurements from MRI images. Neuroradiology (2009) 0.84
Cortical damage in brains of patients with adult-form of myotonic dystrophy type 1 and no or minimal MRI abnormalities. J Neurol (2006) 0.83
Bringing CLARITY to gray matter atrophy. Neuroimage (2014) 0.82
Assessing treatment effects on axonal loss--evidence from MRI monitored clinical trials. J Neurol (2004) 0.82
Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study. J Neurol (2016) 0.82
Reliable measurements of brain atrophy in individual patients with multiple sclerosis. Brain Behav (2016) 0.81
Grey matter lesions in MS: from histology to clinical implications. Prion (2012) 0.81
Progressive multiple sclerosis and gray matter pathology: an MRI perspective. Mt Sinai J Med (2011) 0.81
Longitudinal Changes in White Matter Tract Integrity across the Adult Lifespan and Its Relation to Cortical Thinning. PLoS One (2016) 0.80
Multiple sclerosis: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal (2013) 0.80
Focal and diffuse cortical degenerative changes in a marmoset model of multiple sclerosis. Mult Scler (2010) 0.80
Correlation of Brain Atrophy, Disability, and Spinal Cord Atrophy in a Murine Model of Multiple Sclerosis. J Neuroimaging (2015) 0.79
Structural Brain Network Characteristics Can Differentiate CIS from Early RRMS. Front Neurosci (2016) 0.79
Genetic associations with brain cortical thickness in multiple sclerosis. Genes Brain Behav (2015) 0.78
Gray Matter Correlates of Cognitive Performance Differ between Relapsing-Remitting and Primary-Progressive Multiple Sclerosis. PLoS One (2015) 0.78
BDNF Val66Met polymorphism and brain volumes in multiple sclerosis. Neurol Sci (2010) 0.78
A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis. J Neuroinflammation (2015) 0.78
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis. J Neuroinflammation (2016) 0.77
Disease-modifying drugs reduce cortical lesion accumulation and atrophy progression in relapsing-remitting multiple sclerosis: results from a 48-month extension study. Mult Scler Int (2015) 0.76
Cortical Pathology in RRMS: Taking a Cue from Four Sisters. Mult Scler Int (2012) 0.76
Stepchild or Prodigy? Neuroprotection in Multiple Sclerosis (MS) Research. Int J Mol Sci (2015) 0.76
Neuronopathy in the motor neocortex in a chronic model of multiple sclerosis. J Neuropathol Exp Neurol (2014) 0.75
Regional gray matter atrophy and neuropsychologcal problems in relapsing-remitting multiple sclerosis. Neural Regen Res (2013) 0.75
Systematic imaging review: Multiple Sclerosis. Ann Indian Acad Neurol (2015) 0.75
Reliability of cortical lesion detection on double inversion recovery MRI applying the MAGNIMS-Criteria in multiple sclerosis patients within a 16-months period. PLoS One (2017) 0.75
Frequency doubling illusion VEPs and automated perimetry in multiple sclerosis. Doc Ophthalmol (2006) 0.75
Cognitive dysfunction in different stages in multiple sclerosis--presentation of 3 cases. J Neurol (2007) 0.75
Motor evoked potentials in multiple sclerosis patients without walking limitation: amplitude vs. conduction time abnormalities. J Neurol (2007) 0.75
Correlation between white matter damage and gray matter lesions in multiple sclerosis patients. Neural Regen Res (2017) 0.75
Volumetric Analysis from a Harmonized Multisite Brain MRI Study of a Single Subject with Multiple Sclerosis. AJNR Am J Neuroradiol (2017) 0.75
Consistent resting-state networks across healthy subjects. Proc Natl Acad Sci U S A (2006) 19.60
Temporal autocorrelation in univariate linear modeling of FMRI data. Neuroimage (2001) 12.61
Characterization and propagation of uncertainty in diffusion-weighted MR imaging. Magn Reson Med (2003) 12.09
Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat Neurosci (2003) 10.44
fMRI resting state networks define distinct modes of long-distance interactions in the human brain. Neuroimage (2005) 8.61
Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci (2000) 8.26
Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage (2002) 8.03
Oxygenation dependence of the transverse relaxation time of water protons in whole blood at high field. Biochim Biophys Acta (1982) 7.13
Transgenic plant aequorin reports the effects of touch and cold-shock and elicitors on cytoplasmic calcium. Nature (1991) 6.73
p63 identifies keratinocyte stem cells. Proc Natl Acad Sci U S A (2001) 6.07
Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet (1997) 5.39
Tensorial extensions of independent component analysis for multisubject FMRI analysis. Neuroimage (2005) 5.33
Reduced resting-state brain activity in the "default network" in normal aging. Cereb Cortex (2007) 5.28
Bicycle-associated head injuries and deaths in the United States from 1984 through 1988. How many are preventable? JAMA (1991) 4.76
Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol Psychiatry (2008) 4.70
The Human Connectome Project: a data acquisition perspective. Neuroimage (2012) 4.64
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet (2001) 4.55
Dissociating pain from its anticipation in the human brain. Science (1999) 4.36
Changes in connectivity profiles define functionally distinct regions in human medial frontal cortex. Proc Natl Acad Sci U S A (2004) 4.19
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain (1997) 3.87
134 battered children: a medical and psychological study. Br Med J (1974) 3.85
Resistance gene complexes: evolution and utilization. Annu Rev Phytopathol (2001) 3.80
National probability samples in studies of low-prevalence diseases. Part II: Designing and implementing the HIV cost and services utilization study sample. Health Serv Res (1999) 3.72
Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum (2009) 3.61
Location and clonal analysis of stem cells and their differentiated progeny in the human ocular surface. J Cell Biol (1999) 3.59
The major chlorophyll a/b binding protein of petunia is composed of several polypeptides encoded by a number of distinct nuclear genes. J Mol Appl Genet (1983) 3.54
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study. Lancet Neurol (2009) 3.37
Cryptococcal infections in patients with acquired immune deficiency syndrome. Am J Med (1986) 3.34
Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler (2008) 3.28
Light-stimulated accumulation of transcripts of nuclear and chloroplast genes for ribulosebisphosphate carboxylase. J Mol Appl Genet (1981) 3.28
The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2003) 3.21
Wind-induced plant motion immediately increases cytosolic calcium. Proc Natl Acad Sci U S A (1992) 3.18
Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group. Ann Intern Med (1994) 3.09
Data on the incidence, segregation and linkage relations of the adenylate kinase (AK) polymorphism. Ann Hum Genet (1968) 2.91
Anatomical connectivity of the subgenual cingulate region targeted with deep brain stimulation for treatment-resistant depression. Cereb Cortex (2007) 2.83
Development of resistance in candida isolates from patients receiving prolonged antifungal therapy. Antimicrob Agents Chemother (1991) 2.81
Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol (2001) 2.75
White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry (2002) 2.72
Exacerbation of pain by anxiety is associated with activity in a hippocampal network. J Neurosci (2001) 2.68
Normalized accurate measurement of longitudinal brain change. J Comput Assist Tomogr (2001) 2.67
Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans. FASEB J (1999) 2.61
Activity of ciprofloxacin against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1985) 2.58
Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum. Neurology (2009) 2.46
Genetic control over the resting brain. Proc Natl Acad Sci U S A (2010) 2.45
Risk prediction of prevalent diabetes in a Swiss population using a weighted genetic score--the CoLaus Study. Diabetologia (2009) 2.32
In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1986) 2.29
A critical role for disproportionating enzyme in starch breakdown is revealed by a knock-out mutation in Arabidopsis. Plant J (2001) 2.26
Postgerminative growth and lipid catabolism in oilseeds lacking the glyoxylate cycle. Proc Natl Acad Sci U S A (2000) 2.26
Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria. Antimicrob Agents Chemother (1991) 2.26
Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology (2005) 2.24
Ablation of P/Q-type Ca(2+) channel currents, altered synaptic transmission, and progressive ataxia in mice lacking the alpha(1A)-subunit. Proc Natl Acad Sci U S A (1999) 2.23
Changes in white matter microstructure during adolescence. Neuroimage (2007) 2.22
Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P NMR. Magn Reson Med (1984) 2.21
Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology (2011) 2.17
Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR. EMBO J (1997) 2.16
Pattern of brain tissue loss associated with freezing of gait in Parkinson disease. Neurology (2012) 2.13
A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery. J Crohns Colitis (2012) 2.12
Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology (2006) 2.10
Innate recognition of coral snake pattern by a possible avian predator. Science (1975) 2.07
Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis. Osteoarthritis Cartilage (2011) 2.06
Flows of research manuscripts among scientific journals reveal hidden submission patterns. Science (2012) 2.05
Default-mode network dysfunction and cognitive impairment in progressive MS. Neurology (2010) 2.03
Longitudinal changes in grey and white matter during adolescence. Neuroimage (2009) 2.03
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments. Aliment Pharmacol Ther (2015) 1.99
5-Aminosalicylic acid protects against ischemia/reperfusion-induced gastric bleeding in the rat. Gastroenterology (1988) 1.98
Susceptibility-induced loss of signal: comparing PET and fMRI on a semantic task. Neuroimage (2000) 1.97
Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med (1995) 1.92
An in-vitro and in-vivo comparison of the activity of beta-lactamase inhibitor combinations with imipenem and cephalosporins against Escherichia coli producing TEM-1 or TEM-2 beta-lactamase. J Antimicrob Chemother (1991) 1.91
Removal of FMRI environment artifacts from EEG data using optimal basis sets. Neuroimage (2005) 1.91
MRI criteria for MS in patients with clinically isolated syndromes. Neurology (2010) 1.90
Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. AJNR Am J Neuroradiol (2000) 1.88
Requirement for 3-ketoacyl-CoA thiolase-2 in peroxisome development, fatty acid beta-oxidation and breakdown of triacylglycerol in lipid bodies of Arabidopsis seedlings. Plant J (2001) 1.87
Cognitive and psychosocial features of childhood and juvenile MS. Neurology (2008) 1.85
Transforming growth factor-beta 1 modulates beta 1 and beta 5 integrin receptors and induces the de novo expression of the alpha v beta 6 heterodimer in normal human keratinocytes: implications for wound healing. J Cell Biol (1995) 1.85
Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up. Neurology (2010) 1.85
Over-the-counter medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev (2008) 1.84
Energetics of human muscle: exercise-induced ATP depletion. Magn Reson Med (1986) 1.83
Overview of azathioprine treatment in multiple sclerosis. Lancet (1991) 1.83
Defining a left-lateralized response specific to intelligible speech using fMRI. Cereb Cortex (2003) 1.82
MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett (2000) 1.82
Downregulation of 14-3-3sigma prevents clonal evolution and leads to immortalization of primary human keratinocytes. J Cell Biol (2000) 1.81
Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment. Mult Scler (2005) 1.81
Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis. Neurology (2008) 1.80
Quantitative fMRI assessment of the differences in lateralization of language-related brain activation in patients with temporal lobe epilepsy. Neuroimage (2003) 1.77
Characterisation of three cDNA clones encoding different mRNAs for the precursor to the small subunit of wheat ribulosebisphosphate carboxylase. Nucleic Acids Res (1983) 1.76
Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis. Neurology (2008) 1.76
Saccharomyces cerevisiae infections in man. Sabouraudia (1984) 1.76